In vivo actions of the selective 5-HT1A receptor agonist BAY x 3702 on serotonergic cell firing and release

被引:0
|
作者
Josep M. Casanovas
Olivier Berton
Pau Celada
Francesc Artigas
机构
[1] Department of Neurochemistry,
[2] Institut d'Investigacions Biomèdiques de Barcelona (CSIC),undefined
[3] IDIBAPS,undefined
[4] 6th floor,undefined
[5] Rosselló,undefined
[6] 161,undefined
[7] E-08036 Barcelona,undefined
[8] Spain,undefined
[9] Present address: UCB Pharma,undefined
[10] Preclinical CNS Research Group,undefined
[11] Braine-l'Alleud,undefined
[12] Belgium,undefined
关键词
5-HT1A receptors Dorsal raphe nucleus Hippocampus Median raphe nucleus Microdialysis Prefrontal cortex Single unit recordings;
D O I
暂无
中图分类号
学科分类号
摘要
We investigated the effects of the novel 5-HT1A receptor agonist BAY x 3702 on the serotonergic function in rat brain using single unit recordings in the dorsal raphe nucleus (DR) of anesthetized rats and in vivo microdialysis in freely moving rats. The administration of BAY x 3702 (0.25–4 µg/kg i.v.) suppressed the firing activity of 5-HT neurones. This effect was antagonized by a low dose of the selective 5-HT1A receptor antagonist WAY 100635 (5 µg/kg i.v.).
引用
收藏
页码:248 / 254
页数:6
相关论文
共 50 条
  • [21] F15599, a highly selective serotonin 5-HT1A receptor agonist:: in vivo profile in neurochemical and behavioural models of serotonergic activity
    Assie, M. B.
    Bardin, L.
    Depoortere, R.
    Carilla-Durand, E.
    Newman-Tancredi, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S233 - S233
  • [22] ARE POSTSYNAPTIC 5-HT1A RECEPTORS INVOLVED IN THE ANXIOLYTIC EFFECTS OF 5-HT1A RECEPTOR AGONISTS AND IN THEIR INHIBITORY EFFECTS ON THE FIRING OF SEROTONERGIC NEURONS IN THE RAT
    JOLAS, T
    SCHREIBER, R
    LAPORTE, AM
    CHASTANET, M
    DEVRY, J
    GLASER, T
    ADRIEN, J
    HAMON, M
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1995, 272 (02): : 920 - 929
  • [23] The 5-HT1A receptor antagonist robalzotan completely reverses citalopram-induced inhibition of serotonergic cell firing
    Arborelius, L
    Wallsten, C
    Ahlenius, S
    Svensson, TH
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 382 (02) : 133 - 138
  • [24] 5-HT1A receptor binding in vivo using [3H]-MPPF, a selective 5-HT1A receptor ligand
    Barton, CL
    Jay, MT
    Hutson, PH
    BRITISH JOURNAL OF PHARMACOLOGY, 1998, 125 : U29 - U29
  • [25] ANTIANXIETY AND BEHAVIORAL SUPPRESSANT ACTIONS OF THE NOVEL 5-HT1A RECEPTOR AGONIST, FLESINOXAN
    RODGERS, RJ
    COLE, JC
    DAVIES, A
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1994, 48 (04) : 959 - 963
  • [26] In vivo electrophysiological and neurochemical effects of the selective 5-HT1A receptor agonist, F13640, at pre- and postsynaptic 5-HT1A receptors in the rat
    Laia Lladó-Pelfort
    Marie-Bernadette Assié
    Adrian Newman-Tancredi
    Francesc Artigas
    Pau Celada
    Psychopharmacology, 2012, 221 : 261 - 272
  • [27] In vivo electrophysiological and neurochemical effects of the selective 5-HT1A receptor agonist, F13640, at pre- and postsynaptic 5-HT1A receptors in the rat
    Llado-Pelfort, Laia
    Assie, Marie-Bernadette
    Newman-Tancredi, Adrian
    Artigas, Francesc
    Celada, Pau
    PSYCHOPHARMACOLOGY, 2012, 221 (02) : 261 - 272
  • [28] Quantifying the 5-HT1A agonist actions of buspirone in man
    Marvin, G
    Bridge, MW
    Thompson, CE
    Sharma, A
    Jones, DA
    JOURNAL OF PHYSIOLOGY-LONDON, 2000, 523 : 234P - 234P
  • [29] Preferential in vivo action of F15599, a novel 5-HT1A receptor agonist, at postsynaptic 5-HT1A receptors
    Llado-Pelfort, L.
    Assie, M-B
    Newman-Tancredi, A.
    Artigas, F.
    Celada, P.
    BRITISH JOURNAL OF PHARMACOLOGY, 2010, 160 (08) : 1929 - 1940
  • [30] Occupancy of Agonist Drugs at the 5-HT1A Receptor
    R Alexander Bantick
    Eugenii A Rabiner
    Ella Hirani
    Michiel H de Vries
    Susan P Hume
    Paul M Grasby
    Neuropsychopharmacology, 2004, 29 : 847 - 859